MLPNX
Price
$7.79
Change
+$0.12 (+1.56%)
Updated
Jun 2 closing price
Net Assets
331.2M
OSPPX
Price
$8.05
Change
+$0.13 (+1.64%)
Updated
Jun 2 closing price
Net Assets
331.2M
Interact to see
Advertisement

MLPNX vs OSPPX

Header iconMLPNX vs OSPPX Comparison
Open Charts MLPNX vs OSPPXBanner chart's image
MLPNX vs OSPPX Comparison Chart in %
View a ticker or compare two or three
VS
MLPNX vs. OSPPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPNX is a Buy and OSPPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPNX (331M) and OSPPX (331M) have equal amount of cash in the bank . MLPNX (4.67) and OSPPX (4.52) have matching dividends . MLPNX was incepted earlier than OSPPX: MLPNX (14 years) vs OSPPX (13 years). MLPNX (3.49) and OSPPX (3.42) have similar cost to investors . MLPNX (25.00) and OSPPX (25.00) have comparable annual turnover. MLPNX has a lower initial minimum investment than OSPPX: MLPNX (1000) vs OSPPX (1000000). OSPPX (27.71) and MLPNX (27.60) have marching annual gain over last year. OSPPX (230.08) and MLPNX (228.23) have equivalent 5 years return.
MLPNXOSPPXMLPNX / OSPPX
Total Expense Ratio3.493.42102%
Annual Report Gross Expense Ratio3.493.42102%
Fund Existence14 years13 years-
Gain YTD23.53723.392101%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets331M331M100%
Annual Yield % from dividends4.674.52103%
Returns for 1 year27.6027.71100%
Returns for 3 years126.01126.62100%
Returns for 5 years228.23230.0899%
Returns for 10 years151.44155.5797%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMG310.528.07
+2.67%
Affiliated Managers Group
EPAC33.160.23
+0.70%
Enerpac Tool Group Corp
HBANP16.50-0.10
-0.60%
Huntington Bancshares
MKTW17.14-0.12
-0.67%
MarketWise Inc
AVIR4.28-0.11
-2.40%
Atea Pharmaceuticals